78 related articles for article (PubMed ID: 16403256)
1. [Abnormal expression of hMSH2 mRNA and mutation P53 protein in acute lymphoblastic leukemia].
Lin XY; Sun L; Zou HZ; Le XP; Guo XJ; Liu YF; Sun H; Zou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):948-50. PubMed ID: 16403256
[TBL] [Abstract][Full Text] [Related]
2. Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis.
Wang CX; Wang X; Liu HB; Zhou ZH
Asian Pac J Cancer Prev; 2014; 15(1):355-62. PubMed ID: 24528056
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies.
Tsai T; Davalath S; Rankin C; Radich JP; Head D; Appelbaum FR; Boldt DH
Leukemia; 1996 Dec; 10(12):1901-10. PubMed ID: 8946929
[TBL] [Abstract][Full Text] [Related]
4. Expression of hMSH2 gene and mutant p53 in sporadic digestive tract tumors.
Kang Y; Zhang Z; Wang J; Chen J; Peng B; Kang P
Chin Med J (Engl); 2003 Jan; 116(1):53-6. PubMed ID: 12667388
[TBL] [Abstract][Full Text] [Related]
5. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
6. The IL-6 gene expression by leukemic cells from acute lymphoblastic leukemia common and T type and modulation of IL-6 production by TNF.
Pituch-Noworolska A; Wieckiewicz J; Gawlicka M; Wołoszyn M; Ruggiero I; Zembala M
Haematologia (Budap); 1998; 29(2):101-14. PubMed ID: 9728802
[TBL] [Abstract][Full Text] [Related]
7. Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas.
Hussein MR; El-Ghorori RM; El-Rahman YG
Int J Exp Pathol; 2006 Aug; 87(4):297-306. PubMed ID: 16875495
[TBL] [Abstract][Full Text] [Related]
8. p53 expression and poor prognosis in childhood acute lymphoblastic leukemia.
Hecker S; Sauerbrey A; Volm M
Anticancer Res; 1994; 14(6B):2759-61. PubMed ID: 7872714
[TBL] [Abstract][Full Text] [Related]
9. [The clinical significance of real-time fluorescence PCR quantification of hepatocyte growth factor mRNA expression in acute leukemia].
Cen D; Lü JX; Pei RZ; Tu ZG; Yu XL; Wen YA
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):401-4. PubMed ID: 18953951
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
Sahu GR; Das BR
Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
[TBL] [Abstract][Full Text] [Related]
11. [Expression of MOST-1 mRNA in bone marrow mononuclear cells from patients with acute lymphoblastic leukemia].
Gao J; Yuan LX; Sun L; Li XX; Liao QK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):638-40. PubMed ID: 15460406
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.
Klobusická M; Kusenda J; Babusíkova O
Neoplasma; 2001; 48(6):489-95. PubMed ID: 11949843
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
14. [Study on RNA interference silencing hMSH2 induces the reversal chemo-resistance of ovarian carcinoma cell line OC3/TAX300].
Wang A; Li J; Li H
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):213-7. PubMed ID: 24820308
[TBL] [Abstract][Full Text] [Related]
15. MSH2 deletion with CREBBP and KRAS mutations in pediatric high-hyperdiploid acute lymphoblastic leukemia.
Ueyama JI; Miki M; Okuno K; Eto S; Shimada A
Pediatr Int; 2017 Oct; 59(10):1103-1105. PubMed ID: 28856790
[No Abstract] [Full Text] [Related]
16. Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: correlations with CD surface markers and treatment outcome.
Jiang EZ; Chang YJ; Lee JW; Lee WK; Kim JS; Sohn SK; Lee KB; Suh JS
J Korean Med Sci; 1998 Dec; 13(6):617-22. PubMed ID: 9886170
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells.
Shen JZ; Zhang YY; Fu HY; Wu DS; Zhou HR
Oncol Rep; 2014 May; 31(5):2035-42. PubMed ID: 24626955
[TBL] [Abstract][Full Text] [Related]
18. [Study on expression of cell surface L-selectin and soluble L-selectin in patients with acute leukemia].
Chang JH; Qi ZH; Chen FP; Xie QZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):251-5. PubMed ID: 12844406
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cx43 gene-modified leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro.
Zhang X; Liu Y; Si YJ; Chen XH; Li ZJ; Gao L; Gao L; Zhang C
Leuk Res; 2012 Feb; 36(2):198-204. PubMed ID: 22030334
[TBL] [Abstract][Full Text] [Related]
20. [Expression and sequence analysis of human MutS homologue 2 during different stages of human bronchial epithelial cells induced by cadmium chloride].
Zhou ZH; Lei YX; Wang CX; Wang M; Wei L; Ji WD
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Mar; 26(3):131-4. PubMed ID: 18761787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
